chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain left deltoid / biceps, headache, low-grade temperature; Pain left deltoid / biceps, headache, low-grade temperature; Pain left deltoid / biceps, headache, low-grade temperature; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Aug2021 (Lot number: EW0217) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Morphine, reaction(s): "known allergy: Morphine". The following information was reported: PAIN (non-serious), HEADACHE (non-serious), BODY TEMPERATURE DECREASED (non-serious) all with onset 27Aug2021 05:00, outcome "recovering" and all described as "Pain left deltoid / biceps, headache, low-grade temperature". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain, headache, body temperature decreased.  Additional information: The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine, was not diagnosed with COVID-19 prior to vaccination and had not tested for COVID-19 since the vaccination. Events were treated with Advil 400 mg. Vaccine administration time=03:00 PM.  No follow-up attempts are possible. No further information is expected.
I broke out with a rash, rash all over my body; Fever; I was pretty sick; This is a spontaneous report from a contactable consumer (Patient). This 64-year-old female patient received bnt162b2 (PFIZER COVID 19 VACCINE; Solution for injection; Lot Number: EN5318; Expiry Date: Unknown), dose 2 on an unspecified route of administration on 19Feb2021 as SINGLE DOSE for covid-19 immunization. The patient's medical history included High Blood Pressure. The patient's concomitant medications included Losartan Every morning for High blood pressure. The patient previously received first dose of bnt162b2, lot number EL3248 for Covid-19 immunization. Patient reported that I had my second Covid vaccine done on Friday and I was pretty sick on 19Feb2021, Saturday ran a fever on 20Feb2021. Sunday I felt better but Sunday night I broke out with a rash on 21Feb2021. I have a rash all over my body. I just got home from the doctor's office and he told me to call and report that I have a body rash from this. He gave me some steroids and some cream to put on the rash but I wanted to report that. Treatment received for rash as Prednisone and he gave me Triamcinolone cream. The outcome of the events illness and pyrexia were recovering and outcome of the event rash was unknown.
This spontaneous report was received from a pharmacist referring to a 67 year old male patient. No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.    On 03-NOV-2021, the patient was vaccinated with a first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vial, lot # T000702, 0.5 milliliter in the left arm for prophylaxis (route not reported) which had expired on 01-OCT-2021 (expired product administered). The patient did not experienced any adverse event.
On wednesday 21AUG began having cough; then on 22AUG rash (tiny bumps) appeared on head & neck t100; Was seen on 26AUG by MD & stated ears, lungs & throat clear & felt it was rxn to vax; Pt placed on EES or ESP initially & changed to ceclor
Information has been received from a registered nurse concerning a female patient whose child was vaccinated with a dose of MMR II. Subsequently the mother, whose vaccination history is unknown, broke out in a rash. It was noted that the person with the rash was out of state and the person who called the nurse was going to visit them. It was reported that the nurse has no other information. Unspecified medical attention was sought. Additional information is not expected.
Patient came by pharmacy to report she had bruising on both upper arms from getting VARIVAX (chicken pox) and MMR vaccines. Her arms were also swollen. Vaccines given in deltoid, but not SQ.
1 hr p/fever up to 102 pt given APAP; pt wasn't self; wouldn't eat; laid on couch; another dose of APAP 8PM; MN vomiting, t102.6, lethargic; went to ER this time given APAP @ ER;
Patient was admitted because of sensation of tongue swelling gradually got worse to the point that she has a difficulty swallowing.  She was seen in emergency department 1st time she was evaluated by CT scan of the neck that was essentially negative.  She was given Augmentin 1 dose of Diflucan and prednisone tapering dose and discharged home.   Next day her symptoms got worse with tongue swelling and mucus-like secretion in the mouth that she have a difficulty clearing.  She was experiencing difficulty raising her head with swelling in the tongue.  Denies any cough or shortness of breath.   She was positive for COVID 19 home test 10 days  ago.  First emergency room visit cope with test was done that also resulted positive . She was gi ven IV Solu-Medrol, IV Unasyn.  IMPRESSION: 1. Dysphagia. 2. Mild edema of the larynx and hoarseness. 3. Symptoms likely related to her COVID-19 exposure.
Right after immunization was administered, patient developed an injection site reaction. Patient experienced swelling with slight redness but no itching. Patient was given a cold pack and the swelling was reduced dramatically.
Left anterior thigh with blanching erythema approx. 8 x 10 cm, warm/ slight swelling, non-tender. Right anterior thigh with approx. 1-2 cm area of redness around injection site.
Patient feeling real sick after vaccine; Tested positive for COVID after vaccine; A spontaneous report  was received from a consumer (patient mother) concerning a 59 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events patient feeling real sick after vaccine, tested positive for covid after vaccine.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date in Jan-2021,two weeks prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly at unknown anatomical location for prophylaxis of COVID-19 infection.  On an unknown date in Jan-2021, with in two weeks after first dose of administration, the patient felt real sick and tested positive for COVID after vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, patient feeling real sick after vaccine, positive for covid after vaccine was not reported.; Reporter's Comments: Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the events of feeling sick and COVID-19, are assessed as unlikely related.
Local soreness; also pt. had 3d HX/O URI SX prior to receiving vaccine. Pt. has Asthma. The night he got vaccine he coughed all night and ran fever. Examined the next day and TX'd with URI. RX - Albuterol.
irritation and pain; excessive urination; This spontaneous case was reported by a patient and describes the occurrence of URINARY INCONTINENCE (excessive urination) and URINARY TRACT PAIN (irritation and pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU (Patient only had sore arm.) in October 2020. Concurrent medical conditions included Sulfonamide allergy (Sulfur allergy). Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Apr-2021, the patient experienced URINARY INCONTINENCE (excessive urination). On an unknown date, the patient experienced URINARY TRACT PAIN (irritation and pain). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Pain, at an unspecified dose and frequency. At the time of the report, URINARY INCONTINENCE (excessive urination) was resolving and URINARY TRACT PAIN (irritation and pain) had resolved. Not Provided          Patient had adverse events with both doses of Moderna, but the second shot was much "more pronounced."  The irritation and pain from urination subsided after he took Motrin for lower back pain and it has not come back. 90 percent of his urinary flow went back to normal but when he drinks water there is still a sudden urge to go.
Bleeding consisted of clots; Heavy menstrual bleeding; cramping; This is a spontaneous report from a contactable nurse (patient). A 37-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: FF2587), via an unspecified route of administration, administered in arm left on 17Sep2021 at 15:00 (at the age of 37-years-old) as dose 2, single for COVID-19 immunisation. Medical history included irritable bowel syndrome, migraine, known allergies: penicillin, Food allergies and bee venom. The patient previously received the first dose of BNT162B2 (Batch/Lot Number: FL3180), administered in right arm on 27Aug2021 at 03:00 PM (at the age of 37-years-old) for COVID-19 immunisation. On 18Sep2021 at 07:00, the patient experienced heavy menstrual bleeding out of character/mid cycle for patient; on prescription contraception that typically causes no periods. Bleeding consisted of clots, with cramping, onset 1 day after vaccination. Therapeutic measures were taken as a result of all events. The outcome of the events was not recovered.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of bleeding consisted of clots. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
get shingles after the vaccine/suspected vaccination failure; shingles; i cant work; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and activities of daily living impaired. On an unknown date, the outcome of the vaccination failure, shingles and activities of daily living impaired were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and activities of daily living impaired to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 07-MAY-2022 Reporters comment: The patient self-reported the case via interactive digital media and described the occurrence of suspected vaccination failure. After receiving Shingles vaccine, the patient got shingles. The patient thought he/she was the only one to get shingles after the vaccine. The patient stated that, pharmacist said, the patient might have too many shingles in his/her body and might possibly need another set of vaccine. The patient could not work for 4 to 5 days out of a month. Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory test confirming shingles were unknown at the time of reporting.
Pt reports papular rash day after receiving vaccination.   He was advised to f/u in clinic for evaluation but was not able to be seen.  He was evaluated today 6/15 in clinic with generalized macular/papular rash to BUE and to side of face.  No rash to toroso at this time.   Pt reports severe itching to sites and few on right upper extremity becoming scabbed.
Flu like symptoms, headache, nausea, stiff neck, vomiting, sore throat. Onset of disease 1/17/10. Pat. was admitted to hospital 1/18/10 and released 1/25/10. Neisseria meningitidis was isolated from CSF. Pat. was treated and 9 people received prophylaxis. Specimen was sent to CDC on 2/2/10 for PCR serogroup. It was confirmed to be "Y".
heavy limbs; when trying to hit keyboard with pinky, it hurts; Brain fog; wrist pains in both arms/when you are moving it (trying to type on key board) feels like wrist is going to break; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 02Apr2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 02Apr2021 patient experienced brain fog, wrist pains in both arms/when you are moving it and feels like wrist is going to break and when trying to hit keyboard with pinky, it hurts. Heavy limbs were observed on 03Apr2021. She told her family doctor, she had moments since getting vaccine. She is getting this daily and asks when It is going away. She just wanted to make sure this falls into the classification of Joint and muscle pain. Her doctor said, in a week, tell me how she was feeling. After she got vaccine on 02Apr2021 and experienced experiencing heavy limbs and wrist pain on the 3rd. The wrist pains she was still experiencing in Left side, injections site, it's extremely sensitive, clipping my dogs harness on is bad and she never had arthritis and don't know. Asked Is there a stretch that she should try. The outcome of the event was not recovered for wrist pain and other outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
07/17/2022 pt came in for additional of J&J. When the intern asked which dose she was getting, she stated she was getting her 2nd dose without informing any dose administered outside of the pharmacy. After the intern administered the vaccine, she then told her she got 1st dose somewhere else.   Explained to her the 3rd dose was not recommended for her age, yet it was not contraindicated. Suggested her to monitor closely and call the pharmacy if any side effects happened.
Mother called to report child w/increased temp, Thurs, Fri, Sat of 102. Temp down now. Child has approx 15 measle-like bumps on body. No other problems. Wanted to inform of rash. She had been instructed of possible reactions.
5 days after the first injection in my left upper arm, I developed a silver dollar sized rash on my back near my left shoulder blade.  Within 2 more days I developed more rash areas, all in the upper left quadrant of my body,  above my left breast, under my left arm, and around the original rash site near shoulder blade.  The rash felt itchy, but touching it did not relieve an itch, it was just painful.   This was accompanied by fatigue and headaches, which had continued since the day of injection.  Pain escalated, and I applied cortisone cream and took ibuprofen;  pain made it difficult to sleep;  waking up several times in night in pain.  I did not receive communication until 2 weeks after first vaccination;  I reported this adverse condition but did not receive any phone call or further communication until second 'weekly after vaccination check-in'.    I did not realize this was shingles until a friend mentioned similar experience, and I scheduled a visit to my family doctor, who diagnosed Shingles.  I received the anti-viral and am better.  I am frustrated with lack of follow up by CDC from the first vaccination (2 weeks later) and then no follow up when I reported rash.  I feel like a guinea pig, I feel like a test number, and would have appreciated some reassurance from someone at the CDC while going through this.  I don't feel like the vaccine alone caused the shingles, but I am in the process of moving, and would have delayed getting the vaccine until after the stress of the move was over, or would have gotten the Shingles vaccine, but was never directed to do so by my family doctor or anyone at the vaccine location.  Very dissatisfied.
Redness of L upper deltoid starting d after b/c until present. Approximately 6-8cm redness & L warmth, no itching. BENADRYL recommended.
Guillain Barre Syndrome, Quadriplegia, urinary retention, Immobility, back pain, hypertension (December 2016), Immunoglobulin (December 2016).
Information has been received from a registered nurse concerning a patient who was vaccinated with a last dose of RECOMBIVAX HB.  It was reported that the patient developed an unspecified allergic reaction.  No further information on the patient or the reaction was available at the time of this report.  There was no other information to report.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information has been requested.  Follow-up information from a registered nurse stated that she could not identify the patient and has no further information available to report on this event.  Additional information is not expected.
Fever onset 6-8 hours after immunization with both H1N1 and seasonal Influenza vaccines. Fever 104-105 degrees per parents. Treated with Tylenol and Ibuprofen. Unknown if result of vaccination or other illness.
09May90 pt vax; 15May90 devel irritability & fever 101F.  Tx w/ APAP & tepid sponge baths.  Fever worsened peaking at 103F.  Pt alert.Tx w/ Amoxicillin for possible otitis media.  Fever resolved.
Fever; Chills; Body aches; Intense pain at injection site; Sever shaking; Rapid breathing; Radiating pain throughout whole body, decreased strength; Headache; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 15-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: ew0180; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 04Jun2021 17:00 (at the age of 15-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. The patient previously took amoxicillin and experienced drug hypersensitivity. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: ew0177; Expiration date: unknown) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 05Jun2021 06:00 patient experienced fever, chills, body aches, intense pain at injection site, severe shaking, rapid breathing, radiating pain throughout whole body, decreased strength, headache and fatigue. Patient did not receive any treatment for adverse event. Since the vaccination, patient has not been tested for COVID-19. The outcome of all events was not recovered.  Follow-Up (27Jul2021): Follow-up attempts are completed. No further information is expected.
Vomiting, diarrhea, body aches, fever, swelling. IV fluids for 4 hours in ER
6 days following booster injection, developed burning/itching in left arm from her shoulder to elbow.  The area was red blotches without raised areas. No other areas were affected.   She took Benadryl 25 mg approx 30 minutes later and symptoms resolved by the following morning.
Body aches; Fever; rashes on the whole of her right side, from her under arm to her wasit down to her hips; it is splotchy; Shingles; Prickling/Tingling; Abdominal cramping; numbness; Pruritus; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) from 01-Mar-2018 to an unknown date for Vitamin B12 deficiency.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus). On an unknown date, the patient experienced MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with PREGABALIN for Pain, at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] from 05-May-2021 to 12-May-2021 for Shingles, at a dose of 1 gram three times a day. At the time of the report, HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus) had not resolved and MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient feels like a bad sunburn at the site of rash.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up information received and concomitant product, treatment information and event shingles were added. On 25-Jun-2021: Follow-up information received and new Events and Treatment medication were added.
This case was reported by a healthcare professional and described the occurrence of swelling injection site in a child subject of unspecified gender who was vaccinated with DTAP (manufacturer unspecified) for prophylaxis. On 5 March 2008 the subject received 4th dose of DTAP in the left thigh. At an unspecified time after vaccination with DTAP, the subject experienced swelling injection site and injection site redness, local reactions. At the time of reporting the outcome of the events was unspecified.
Patient vaccinated 12/29/20 and 1/19/21.   Patient asymptomatic on 2/26/2021 but tested for COVID-19.  PCR positive.
Gave shot, patients throat started to itch, and face got red with hives.  Gave 25 mg benydrl and called EMS
Fever 102 after Imms, then rash and swelling with a little clear fld leaking from MMRV imm site. She's using her arm like normal, still itchy at times, looking better now. Cool compress for comfort.
Pt left here after receiving shot- said she was in a restaurant drive through about 20 minutes later & felt like she was going to pass out-called 911 no epi administered.
Information has been received from a physician who reported in a magazine article regarding Cervical Cancer and in the article physician stated that "GARDASIL has caused 70 young healthy girls to die right after receiving the vaccine due to neurological problems. CERVARIX is covering three other HPV strains and it has been proven." No further AE information filed. There was no specific patient information, physician information, or date of death for the 70 patients in the article. Neurological problems considered to be immediately life-threatening. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.